Key result
Genetic testing identifies a novel TGFBR2 mutation confirming late-presenting Loeys-Dietz syndrome requiring aortic root repair.
Why the study?
Loeys-Dietz syndrome is a rare autosomal dominant connective tissue disease characterized by aggressive arterial aneurysms with a mean age at death of 26.1 years, and this report describes an unusually late presentation in a female with a long history of joint hypermobility.
Case Report (n=1)
This case highlights the potential for an unusually late presentation of Loeys-Dietz syndrome and emphasizes the importance of timely recognition of inherited vasculopathy syndromes in patients presenting with joint hypermobility.
Answers are grounded in this paper and cite their sources.
Late Loeys-Dietz presentations occur; extends phenotypic spectrum but leaves screening thresholds open.
Background: Thoracic aortic aneurysms (TAA) and dissections are not uncommon causes of sudden death in young adults. Loeys-Dietz syndrome (LDS) is a rare, recently described, autosomal dominant, connective tissue disease characterized by aggressive arterial aneurysms, resulting from mutations in the transforming growth factor beta (TGFβ) receptor genes TGFBR1 and TGFBR2. Mean age at death is 26.1 years, most often due to aortic dissection. We report an unusually late presentation of LDS, diagnosed following elective surgery in a female with a long history of joint hypermobility. Methods: A 51-year-old Caucasian lady complained of chest pain and headache following a dural leak from spinal anaesthesia for an elective ankle arthroscopy. CT scan and echocardiography demonstrated a dilated aortic root and significant aortic regurgitation. MRA demonstrated aortic tortuosity, an infrarenal aortic aneurysm and aneurysms in the left renal and right internal mammary arteries. She underwent aortic root repair and aortic valve replacement. She had a background of long-standing joint pains secondary to hypermobility, easy bruising, unusual fracture susceptibility and mild bronchiectasis. She had one healthy child age 32, after which she suffered a uterine prolapse. Examination revealed mild Marfanoid features. Uvula, skin and ophthalmological examination was normal. Results: Fibrillin-1 testing for Marfan syndrome (MFS) was negative. Detection of a c.1270G > C (p.Gly424Arg) TGFBR2 mutation confirmed the diagnosis of LDS. Losartan was started for vascular protection. Conclusions: LDS is a severe inherited vasculopathy that usually presents in childhood. It is characterized by aortic root dilatation and ascending aneurysms. There is a higher risk of aortic dissection compared with MFS. Clinical features overlap with MFS and Ehlers Danlos syndrome Type IV, but differentiating dysmorphogenic features include ocular hypertelorism, bifid uvula and cleft palate. Echocardiography and MRA or CT scanning from head to pelvis is recommended to establish the extent of vascular involvement. Management involves early surgical intervention, including early valve-sparing aortic root replacement, genetic counselling and close monitoring in pregnancy. Despite being caused by loss of function mutations in either TGFβ receptor, paradoxical activation of TGFβ signalling is seen, suggesting that TGFβ antagonism may confer disease modifying effects similar to those observed in MFS. TGFβ antagonism can be achieved with angiotensin antagonists, such as Losartan, which is able to delay aortic aneurysm development in preclinical models and in patients with MFS. Our case emphasizes the importance of timely recognition of vasculopathy syndromes in patients with hypermobility and the need for early surgical intervention. It also highlights their heterogeneity and the potential for late presentation. Disclosures: The authors have declared no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2013) conducted a case report in Loeys-Dietz syndrome presenting with dilated aortic root, significant aortic regurgitation, aortic tortuosity, and multiple arterial aneurysms (n=1). Aortic root repair, aortic valve replacement, and losartan was evaluated on Confirmation of Loeys-Dietz syndrome diagnosis and management. Genetic testing identified a c.1270G>C TGFBR2 mutation confirming late-presenting Loeys-Dietz syndrome in a 51-year-old female treated with aortic root repair, AVR, and losartan.
Synapse has enriched 10 related papers. Consider them for comparative context: